fda stop tirzepatide reconsidering its decision to take off its drug shortage list The FDA says the Zepbound

Opinions on GLP-1 regulation are mixed: 40% think the current rules are fair, 28% want fewer restrictions, and 22% think there should be more

Prescription treatments are only available after completing an online consultation with a qualified provider

GLP-1 targets areas of the brain that regulate appetite and blood sugar

A comprehensive assessment will determine if you are a good candidate

10,11 A rapid decay in circulation, coupled with less than 2 minutes of half-life of GLP-1 by dipeptidyl peptidase-IV (DPP-IV), caused researchers to develop GLP-1R agonists or DPP-IV inhibitors aimed at maintaining the effects of GLP-1 in pharmacological or physiological concentration, respectively